Literature DB >> 27023717

Evaluation of LRINEC Scale Feasibility for Predicting Outcomes of Fournier Gangrene.

Marius Kincius1, Titas Telksnys2, Darius Trumbeckas1, Mindaugas Jievaltas1, Daimantas Milonas1.   

Abstract

BACKGROUND: Fournier gangrene (FG) is a fulminant necrotizing infection of the perineal, perianal, and periurethral tissues. The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) scale is used for diagnosis of necrotizing fasciitis. However, data on its relevance and usefulness in FG are lacking. The aim of this study was to evaluate the utility of the LRINEC scale in predicting the outcome of FG.
METHODS: This retrospective case study included 41 patents with FG treated at our institution from 2000 to 2013. The patients were divided into survivors and non-survivors.
RESULTS: The mortality rate was 22%. The median age (75 vs. 62.5 y; p = 0.013), rate of co-existing diabetes mellitus (66.7% vs. 3.1%; p < 0.001), and median affected skin surface (4% vs. 1%; p < 0.001) were greater in the non-survivors. Seven of nine patients (77.8%) who did not survive (compared with 37.5% who survived) had a polymicrobial infection (p = 0.032). Of all the causative pathogens isolated, Proteus mirabilis was more common in non-survivors (55.6% vs. 6.3%; p = 0.001). The median calculated LRINEC score for survivors was 5 compared with 10 for the non-survivors (p < 0.001). Regression analysis showed that all the aforementioned variables, except for polymicrobial culture, were significant risk factors for predicting death. The area under the receiver operating characteristic curve for the LRINEC score was the highest, 0.976 (95% confidence interval 0.872-0.999; p < 0.0001), and the cut-off value was ≥9 with 93.7% specificity and 100% susceptibility for the prediction of a lethal outcome.
CONCLUSIONS: The LRINEC score could be used for prediction of disease severity and outcomes. A threshold of 9 could be a high-value predictor of death during the initial evaluation of patients with FG.

Entities:  

Mesh:

Year:  2016        PMID: 27023717     DOI: 10.1089/sur.2015.076

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  8 in total

Review 1.  Evaluation and Management of Necrotizing Soft Tissue Infections.

Authors:  Stephanie L Bonne; Sameer S Kadri
Journal:  Infect Dis Clin North Am       Date:  2017-09       Impact factor: 5.982

Review 2.  Fournier's Gangrene: Literature Review and Clinical Cases.

Authors:  Sergey A Chernyadyev; Marina A Ufimtseva; Irina F Vishnevskaya; Yuri M Bochkarev; Alexey A Ushakov; Tatiana A Beresneva; Farid V Galimzyanov; Valery V Khodakov
Journal:  Urol Int       Date:  2018-06-27       Impact factor: 2.089

Review 3.  Necrotizing fasciitis: case series and review of the literature on clinical and medico-legal diagnostic challenges.

Authors:  Paolo Fais; Alessia Viero; Guido Viel; Renzo Giordano; Dario Raniero; Stefano Kusstatscher; Chiara Giraudo; Giovanni Cecchetto; Massimo Montisci
Journal:  Int J Legal Med       Date:  2018-04-07       Impact factor: 2.686

Review 4.  [Necrotizing fasciitis of the upper and lower extremities].

Authors:  M Kückelhaus; T Hirsch; M Lehnhardt; A Daigeler
Journal:  Chirurg       Date:  2017-04       Impact factor: 0.955

5.  Pattern and outcome of management of Fournier's gangrene in a resource-constraint setting.

Authors:  Ngwobia Peter Agwu; Abubakar Sadiq Muhammad; Abdulwahab-Ahmed Abdullahi; Bello Bashir; Jacob Ndas Legbo; Ismaila Arzika Mungadi
Journal:  Urol Ann       Date:  2020-07-17

6.  Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospective study.

Authors:  Marco Bo Hansen; Lars Simon Rasmussen; Mattias Svensson; Bhavya Chakrakodi; Trond Bruun; Martin Bruun Madsen; Anders Perner; Peter Garred; Ole Hyldegaard; Anna Norrby-Teglund
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

7.  Case series of Fournier's gangrene: Affected body surface area - The underestimated prognostic factor.

Authors:  Henrique Morais; Jessica Neves; Hugo Maciel Ribeiro; Marta Ferreira; Narcisa Guimarães; Nuno Azenha; Raquel Dias; Alice Fonseca; Lucilia Conceição
Journal:  Ann Med Surg (Lond)       Date:  2017-02-27

Review 8.  Fournier's Gangrene: A Coexistence or Consanguinity of SGLT-2 Inhibitor Therapy.

Authors:  Tutul Chowdhury; Nicole Gousy; Amulya Bellamkonda; Jui Dutta; Chowdhury F Zaman; Ummul B Zakia; Tasniem Tasha; Priyata Dutta; Padmaja Deb Roy; Adriana M Gomez; Arjun Mainali
Journal:  Cureus       Date:  2022-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.